© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
May 13, 2015
Selection of optimal antibiotic therapy is crucial in the treatment of MRSA.
May 12, 2015
Clinical Care Focus
Though clinically significant, NOH has had few treatment options.
According to FDA-approved labeling, use of dabigatran and edoxaban for acute VTE treatment requires 5 to 10 days of parenteral anticoagulation.
May 11, 2015
Chronic Care Focus
Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
Formulary Drug Review
Keytruda, manufactured by Merck, is indicated for treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and a BRAF inhibitor.
For the last few decades, the formulary has been part of a consistent foundation for all hospital pharmacies.